Back to the im­munol­o­gy draw­ing board, Ab­b­Vie inks dis­cov­ery deal with old Al­ler­gan part­ner

Al­ler­gan’s neu­rol­o­gy-fo­cused R&D pact with So­sei Hep­tares hasn’t been all ros­es, but the BD team at Ab­b­Vie found enough to like about the G …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.